Stemline Therapeutics Inc.

NY · United States · Reporting entity ID 100000481815

Total reported 2019–2025

$32.3M

#223 of 2,960 reporting companies — 0% of all reported industry payments

$7.71M in general payments across 26,645 records, plus $24.6M in research funding across 4,068 records.

How it breaks down

General payments $7,714,333

Research funding $24,586,906

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.